sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_8 ;
    pav:version "1.4" .
  sub:_7 prov:value "Conversely, insulin-stimulated PI(3)K activity was increased by 80% in muscle of both Rbp+/- and Rbp4-/- mice compared with control mice (Fig. 5b). However, PI(3)K activity was not altered in the liver of RBP4-Tg (Fig. 5c) or Rbp4-/- mice (Fig. 5d). Consistent with these observations, RBP4 injection for 21 days in wild-type mice caused a 34% reduction in insulin-stimulated PI(3)K activity in muscle, but no alteration in liver (Fig. 5e). Furthermore, RBP4 treatment resulted in a 24% reduction in insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1 (IRS1) at tyrosine residue 612 (Fig. 5f), an important docking site for the p85 subunit of PI(3)K23." ;
    prov:wasQuotedFrom pubmed:16034410 .
  sub:_8 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:16034410 ;
    prov:wasDerivedFrom beldoc: , sub:_7 .
}